mann kind — 2154277
Application number
2154277
Registration number
TMA1224446
International Registration Number
1633006
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2021-06-22
International Registration
2021-06-22
Registered
2024-03-07
Registration Expiry Date
2031-06-22
Registered Owner
MannKind Corporation
1 Casper Street
Danbury CT 06810
UNITED STATES OF AMERICA
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Trademark description
The mark consists of the term "MANN" with the term "KIND" below it all within a circle design.
Index headings
- MANNKIND
- MANKIND
- MANN KIND
- MAN
Vienna information (Code & Description)
- 26.1.1
- Circles
- A 26.1.3
- One circle or ellipse
- A 26.1.18
- Circles or ellipses containing one or more letters
- A 26.1.24
- Circles or ellipses with dark surfaces or parts of surfaces
Services (Nice class & Statement)
- 41
- (1) Arranging and conducting conferences, seminars and non-downloadable webinars in the field of health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing non-downloadable podcasts in the field of mental and physical health and wellness, healthcare, patient support services, pharmaceuticals, patient access to pharmaceuticals, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
- 44
- (2) Provision of information in the fields of mental and physical health and wellness, healthcare, patient support services, pharmaceuticals, patient access to pharmaceuticals, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals via a website.
Claims
- Priority Filing Date: December 22, 2020, Country or Office: UNITED STATES OF AMERICA, Application No. 90403268 in association with the same kind of services
Recordals (known also as Footnotes)
CHANGE IN TITLE / CHANGEMENT EN TITRE: TYPE OF CHANGE / GENRE DE CHANGEMENT: Name and Address / Nom et adresse DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2023-06-14 DATE OF CHANGE / DATE DE CHANGEMENT: 2023-05-11 COMMENTS / COMMENTAIRES: From: MannKind Corporation To: MannKind CorporationAction History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| International Registration | 2021-06-22 | 2031-06-22 | |
| Filed | 2021-06-22 | Registration | |
| Formalized | 2021-12-15 | ||
| Created | 2021-12-15 | ||
| Designation Notification - Madrid Protocol | 2021-12-16 | 2023-06-16 | |
| Search Recorded | 2022-04-04 | ||
| Examiner's First Report | 2022-04-04 | 2022-10-04 | |
| Total Provisional Refusal | 2022-04-04 | 2022-10-04 | |
| Agent Changed | 2022-04-26 | From/De: To/A: 9681 | |
| Extension of Time | 2022-09-13 | 2023-04-04 | Request Letter Date: 2022/08/29 |
| Agent Name Changed | 2022-10-07 | ||
| Notification of Possible Opposition Sent | 2022-10-17 | ||
| Amendment to Application | 2023-06-15 | DP:2023-06-14 Effective Date: 2023-05-11 | |
| Approval Notice Sent | 2023-11-21 | APPROVED BY PROGRAM EX200M1 | |
| Approved | 2023-11-21 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2023-12-20 | Vol.70 Issue 3608 | |
| Opposition Start Date Notice Sent | 2023-12-20 | Requested on 2023/12/20 00:30:09 in program jr500m1 | |
| Registration Pending | 2024-03-07 | ||
| Registered | 2024-03-07 | ||
| Statement of Grant of Protection Sent (following a Provisional Refusal) | 2024-03-07 | ||
| Agent Changed | 2026-04-21 | Transferred From: 9681 To: 59 |